Health News

Study aims to optimize device implantation in patients with atrial fibrillation and stroke risk

 8 months ago       133 Views

According to clinical studies, about a third of patients with atrial fibrillation will suffer a stroke during their lifetime. Between 70 and 90% of these strokes are caused by a thrombus formed in the left atrial appendage.

In patients with contraindications to oral anticoagulants, a left atrial appendage occluder (LAAO) is often implanted to prevent blood flow entering in the LAA. But this strategy is not without problems and often the success of the device depends on the clinician's experience. Implementation can even lead to blood clots outside the device, eventually leading to stroke if not treated.

The aim of a study, published in March in Frontiers in Physiology, was to develop tools based on biophysical models and interactive interfaces to optimize LAAO device therapies. The study was led by Òscar Camara, a researcher with the Physense Research Group, which is a part of the BCN MedTech Unit at the UPF Department of Information and Communication Technologies (DTIC).


Author: @DailyCupofYoga

Source: news-medical.net

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.